American Capital Advisory’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
American Capital Advisory's AMGN Position: Q2 2026 in Review
American Capital Advisory increased its Amgen (AMGN) stake by 4.1% in Q2 2026, buying an estimated $12.3K and bringing the position to 921 shares worth $334K. The position accounts for 0.12% of the portfolio, ranked #85.
American Capital Advisory first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- American Capital Advisory held 921 shares of Amgen worth $334K as of Q2 2026.
- American Capital Advisory bought 36 Amgen shares in Q2 2026, an estimated $12.3K.
- Amgen made up 0.12% of American Capital Advisory's portfolio in Q2 2026, its #85 holding.
- American Capital Advisory first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.